Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 854–855 | Cite as

ASO Author Reflections: Decision Timing for Organ Preservation in Rectal Cancer After Chemoradiation

  • Britt J. P. Hupkens
  • Monique MaasEmail author
ASO Author Reflections
  • 53 Downloads

Notes

Disclosures

The author has no conflicts of interest to disclose.

References

  1. 1.
    Van der Valk, MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–45.  https://doi.org/10.1016/s0140-6736(18)31078-x.CrossRefGoogle Scholar
  2. 2.
    Maas M, Lambregts DM, Nelemans PJ, et al. Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Ann Surg Oncol. 2015;22(12):3873–80.CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Sloothaak DA, Geijsen DE, van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013;100(7):933–9.CrossRefGoogle Scholar
  4. 4.
    Hupkens BJP, Maas M, Martens MH, et al. Organ preservation in rectal cancer after chemoradiation: should we extend the observation period in patients with a clinical near-complete response? Ann Surg Oncol. 2018;25(1):197–203.  https://doi.org/10.1245/s10434-017-6213-8.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of SurgeryZuyderland Medical CentreHeerlen, SittardThe Netherlands
  2. 2.Department of RadiologyNetherlands Cancer InstituteAmsterdamThe Netherlands

Personalised recommendations